Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer- Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial JAMA Oncology, July 9, 2020

Hot Topics of the Day|PHGKB


Last Posted: Jul 10, 2020

---

• Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer- Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
  JAMA Oncology, July 9, 2020
• Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer
  D Nguyen et al, JAMA Network Open, July 9, 2020
• Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
  Corso Giovanni et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019 Oct 45(10) 1760-1761
• Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes.
  Wang Jiayu et al. Cancer medicine 2019 8(5) 2074-2084
• Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis.
  Wang Shi-Yi et al. Journal of the National Comprehensive Cancer Network : JNCCN 2019 17(1) 39-46
• Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.
  Shin Seung Jun et al. Cancer research 2020 80(2) 354-360
• The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.
  Di Cosimo Serena et al. European journal of cancer (Oxford, England : 1990) 2019 1181-9
• The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.
  Rajagopal Padma Sheila et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 37(24) 2177-2178
• Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
  Nones K et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 30(7) 1071-1079
• Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?
  Whitaker Kristen D et al. Breast cancer research and treatment 2020 Jul

more